Kiora Pharmaceuticals Inc...

NASDAQ: KPRX · Real-Time Price · USD
2.93
0.40 (15.81%)
At close: Aug 15, 2025, 3:59 PM
2.93
0.00%
After-hours: Aug 15, 2025, 05:46 PM EDT

Kiora Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 20K 16.02M 16.3M 16.3M 16.28M 283.87K n/a n/a n/a n/a n/a n/a n/a n/a 12.06K 12.06K 12.06K
Cost of Revenue
99.42K 85.81K 82.41K 56.25K 84.41K 123.23K 149.87K 152.22K 146.44K 656.97K 675.99K 725.2K 746.78K 239.06K 227.27K 885.39K 1.81M 2.38M
Gross Profit
-16.05M -16.91M -903.03K 15.36M 14.29M 15.12M -908.63K -1.19M -146.44K -656.97K -675.99K -725.2K -746.78K -239.06K -227.27K -873.33K -1.8M -2.37M
Operating Income
-10.89M -11.04M 4.5M 4.94M 2.63M 2.54M -12.59M -13.1M -10.89M -10.66M -12.31M -18.32M -17.59M -17.93M -16.94M -10.81M -9.85M -8.82M
Interest Income
1.19M 1.31M 1.25M 859.51K 660.59K 363.57K 173.99K 185.35K 143.3K 99.45K 66.21K 9.62K 2.01K 1.11K 1.14K 1.06K 1.14K 5.14K
Pretax Income
-9.91M -9.86M 5.66M 5.64M 3.29M 2.9M -12.42M -12.86M -12.21M -12M -13.7M -19.77M -17.62M -17.68M -16.7M -10.42M -9.46M -8.71M
Net Income
-11.98M -12.05M 3.59M 5.55M 3.2M 2.81M -12.88M -13.34M -14.11M -13.9M -15.22M -20.88M -17.31M -17.37M -16.39M -10.43M -9.47M -8.72M
Selling & General & Admin
5.55M 5.74M 5.53M 5.07M 5.11M 4.67M 4.66M 6.56M 7.18M 7.88M 8.28M 6.88M 6.18M 5.69M 5.32M 5.46M 5.14M 4.93M
Research & Development
10.56M 8.88M 7.84M 4.83M 4.6M 5.08M 4.03M 3.76M 4M 3.18M 3.45M 3.61M 3.91M 4.78M 5.35M 5.36M 4.72M 3.91M
Other Expenses
-9.54M -10.33M -6.11M -2.25M -825.29K -64.73K -50.06K 2.32M -10.29K 48.55K 1.23M 7.5M 7.5M 7.47M 6.27M n/a n/a n/a
Operating Expenses
6.57M 4.29M 7.26M 7.65M 8.88M 9.71M 8.64M 12.65M 11.18M 11.06M 11.73M 10.49M 10.09M 10.47M 10.67M 10.82M 9.86M 8.83M
Interest Expense
21.45K 21.45K 21.45K n/a n/a n/a n/a 738.00 738.00 738.00 738.00 4.13K 4.13K 6.17K 6.85K 6.91K 6.91K 4.87K
Selling & Marketing Expenses
n/a n/a -16.21K -24.15K -24.15K -24.15K -7.93K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.76M 11.06M 11.52M 11.08M 13.39M 13.32M 12.23M 13.74M 11.18M 11.06M 11.73M 10.49M 10.09M 10.47M 10.67M 10.82M 9.86M 8.83M
Income Tax Expense
1.83M 1.94M 2.07M 90.32K 90.32K 90.32K 460.04K 482.73K 1.9M 1.9M 1.52M 1.72M 300.61K 302.64K 307.32K 14.6K 14.67K 16.98K
Shares Outstanding (Basic)
3.99M 4.22M 3M 4.21M 4.17M 25.94M 7.71M 7.11M 3.29M 1.86M 1.8M 848.53K 326.64K 316.38K 256.63K 256.63K 186.66K 183.95K
Shares Outstanding (Diluted)
3.99M 4.22M 3M 4.21M 4.17M 35.03M 7.71M 7.11M 3.29M 1.86M 1.8M 848.53K 326.64K 326.46K 256.63K 267.59K 186.66K 183.95K
EPS (Basic)
-3.28 -3.27 1.92 3.04 3.04 2.78 -3.09 -4.32 -11.21 -17.77 -27.82 -58.95 -62.81 -68.69 -71.47 -60.07 -66.16 -68.06
EPS (Diluted)
-3.28 -3.27 0.71 1.83 1.83 1.57 -3.09 -4.32 -11.21 -17.77 -27.48 -58.61 -62 -67.88 -71 -59.6 -66.16 -68.06
EBITDA
-9.48M -9.67M 5.85M 6.18M 6.39M 6.34M -8.82M -9.25M -10.12M -10.01M -10.67M -13.95M -13.56M -13.61M -13.78M -10.33M -9.37M -8.67M
EBIT
-9.52M -9.68M 5.58M 2.37M 2.57M 2.51M -12.41M -12.28M -13.14M -13.02M -13.69M -16.79M -16.39M -16.56M -16.2M -9.92M -8.96M -8.13M
Depreciation & Amortization
39.82K 26.2K 42.1K 44.12K 53.33K 92.15K 118.8K 121.15K 146.44K 136.16K 155.18K 204.4K 225.98K 239.06K 227.27K 176.83K 127.28K 76.42K